PharmiWeb
Lilly and EVA Pharma collaborate to expand access to baricitinib in low- to middle-income countries
Eli Lilly and Company (NYSE: LLY) and EVA Pharma announced today that the companies have entered into an agreement to expand access to baricitinib to an estimated 20,000 people in 49 low- to ...
2 days ago